ID: ALA3647701

Max Phase: Preclinical

Molecular Formula: C78H102N16O9S

Molecular Weight: 1439.84

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O

Standard InChI:  InChI=1S/C78H102N16O9S/c1-48(95)69-77(103)92-63(39-49-20-6-3-7-21-49)70(96)83-34-17-15-29-60(82-36-37-104-47-52-38-57-56-27-18-31-59-68(56)54(45-86-59)43-67(57)94(2)46-52)71(97)87-62(32-19-35-84-78(80)81)72(98)89-64(40-50-22-8-4-9-23-50)74(100)90-65(41-51-24-10-5-11-25-51)75(101)91-66(42-53-44-85-58-28-13-12-26-55(53)58)76(102)88-61(73(99)93-69)30-14-16-33-79/h3-13,18,20-28,31,44-45,48,52,57,60-67,69,82,85-86,95H,14-17,19,29-30,32-43,46-47,79H2,1-2H3,(H,83,96)(H,87,97)(H,88,102)(H,89,98)(H,90,100)(H,91,101)(H,92,103)(H,93,99)(H4,80,81,84)/t48-,52-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/m1/s1

Standard InChI Key:  RLNOIVAKZZSAAF-AJOPKFPVSA-N

Associated Targets(Human)

Somatostatin receptor 1 861 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Somatostatin receptor 2 1526 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine D2 receptor 23596 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1439.84Molecular Weight (Monoisotopic): 1438.7736AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1.  (2015)  Somatostatin-dopamine chimeric analogs, 

Source

Source(1):